Your browser doesn't support javascript.
loading
Case report: Tisagenlecleucel for treatment of relapsed B- acute lymphoblastic leukemia in a patient with CHEK2 mutation.
Ipe, Abraham; Angiolillo, Anne; Jacobsohn, David; Cheng, Jinjun; Bornhorst, Miriam; Turner, Joyce; Vatsayan, Anant.
Affiliation
  • Ipe A; School of Medicine and Health Sciences, George Washington University, Washington, DC, United States.
  • Angiolillo A; School of Medicine and Health Sciences, George Washington University, Washington, DC, United States.
  • Jacobsohn D; Department of Leukemia/Lymphoma, Children's National Hospital, Washington, DC, United States.
  • Cheng J; School of Medicine and Health Sciences, George Washington University, Washington, DC, United States.
  • Bornhorst M; Department of Blood and Marrow Transplantation, Children's National Hospital, Washington, DC, United States.
  • Turner J; School of Medicine and Health Sciences, George Washington University, Washington, DC, United States.
  • Vatsayan A; Department of Hematopathology, Children's National Hospital, Washington, DC, United States.
Front Pediatr ; 11: 1067131, 2023.
Article in En | MEDLINE | ID: mdl-36937957
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pediatr Year: 2023 Document type: Article Affiliation country: United States Country of publication: Switzerland
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Prognostic_studies / Risk_factors_studies Language: En Journal: Front Pediatr Year: 2023 Document type: Article Affiliation country: United States Country of publication: Switzerland